Introduction
Genital herpesvirus infection is the third most common sexually transmitted disease diagnosed at the Harborview Medical Center at Seattle. Previous studies on prevalence have shown that herpes simplex virus (HSV) is detected in the cervix in 0-6 % of pregnant women (Bolognese et al., 1976) and in 5 8 % of female patients seen in a clinic for sexually transmitted diseases (STD) (Wentworth et al., 1973) . Seroepidemiological studies have shown that while antibody prevalence to either type 1 or type 2 virus varies with age, race, gravidity, and sexual experience antibody to HSV-2 is often found in patients without a history of clinical genital disease (Rawls et al., 1970) . These data suggest that genital HSV infection may initially be asymptomatic or mildly symptomatic. Cytological evidence of herpes group virus infection from cervical preparations often occurs in the absence of vulval disease (Ng et al., 1970) . Recent investigations have also indicated that cervical infection with HSV as demonstrated by either viral isolation or cytological changes in cervical cells was more often present in women with initial genital infection (87 %) than in women with recurrent genital disease (4 %) (Adams et al., 1976) . In addition, 206 routine cervical cultures obtained after the first genital infection had resolved revealed no evidence of recurrent cervical HSV infection (Rattray et al., 1976) .
To investigate whether asymptomatic cervical excretion of herpes simplex virus occurs in women with recurrent vulval disease and to quantitate the frequency and duration of asymptomatic viral shedding we prospectively followed a small cohort of women with documented genital disease.
Materials and methods
Six women (Table 1) with previously culturally proved genital HSV infection were investigated twice weekly for a mean of 32 weeks (range 13-48 (Benjamin, 1974) . Complement fixation titres were recurrent genital disease. performed as previously described (Wentworth and Asymptomatic viral shedding was recorded in Alexander, 1971 Before entering the study, four of the six women felt that their recurrences were precipitated by the onset of menses. When the date of onset of recurrences was analysed by time of menstrual cycle ( Figure) , no discernible relationship between menstrual period and onset of recurrent genital infection was present. Sixty-five per cent of recurrences began during midcycle, 23% during menses, and 11 % in the five days preceding menses. It should be noted, however, that 24 of the 26 recurrences occurred in women taking oral contraceptives, and it is not known whether this mode of contraception affects the recurrence pattern of genital herpesvirus infection.
In addition, there was no obvious relationship between sexual activity and recurrent herpes virus infection in these women. All the women were sexually active. The mean number of days between last sexual contact and positive herpes cultures was 2-0 days compared with 2-7 days between last sexual contact and those visits not associated with recurrence (P>_ 0-05 (t test)).
Discussion
In this study of women with recurrent genital herpes asymptomatic viral shedding accounted for 14% of Figure Onset ofgenital herpesvirus recurrence by day of menstrual cycle among women with recurrent disease the HSV culture-positive recurrences. In women with recurrent disease, both asymptomatic herpetic lesions and transient shedding of HSV from cervix or vulva without obvious herpetic lesions were documented. These data appear analogous to those of Douglas and Couch (1970) , who reported that 2 2% of saliva specimens taken from asymptomatic patients with serological evidence of infection were positive for HSV (Douglas and Couch, 1970) . Thus studies of the natural history and prevention of recurrent herpes should examine both symptomatic and asymptomatic disease.
The role that asymptomatic viral shedding may play in the transmission of genital HSV infections is unknown. Many patients presenting with initial genital HSV infections have sexual partners without recent signs or symptoms of infection. These contacts usually have serum antibody to HSV, but no clinically detectable HSV infections are present when they are examined. The data from this study suggest that these sexual partners may have had unnoticed lesions or transient shedding of HSV from the cervix or other sites without lesions.
Thiee of the six women with recurrent vulval disease shed HSV from the cervix at some time during the course of the investigation. It is possible that some women with recurrent genital herpes do not develop cervical recurrences and may have a risk of cervical carcinoma which differs from the risk seen in women with recurrent cervical shedding (Naib et al., 1966; Rawls et al., 1976) .
The frequency of recurrence of genital disease was greater in women who had a history of genital herpes for less than 12 months before the beginning of the study (2-22 recurrences per 100 patient days) than in those with genital HSV of more than two years' duration (0 77 recurrences per 100 patient days). Further analyses of the frequency of recurrence in a larger numbet of intensively studied patients are needed to determine whether there is a decrease in the rate of shedding of HSV or a change with time in the pattern of symptoms associated with recurrence.
While all six women claimed that their herpetic recurrences were related to either menses or sexual activity, no discernible patterns between mtnses or sexual intercourse and the onset of recurrences were found. Fifteen recurrences began during days 7-21 of the cycle, and 12 recurrences began in the two weeks before and including the menses.
In previous studies the frequency of recurrence of genital herpes was found to be greater in men than women (Corey et al., 1976; Vontver et al., 1978) . Whether this increased frequency of recurrence in men is due to a difference in the rate of viral shedding of HSV in men compared with women or if self-detection of trivial herpetic lesions is easier in men than in women remains unknown. Similar studies are needed in men to investigate the arnatomical site, frequency, duration, and potential transmissibility of asymptomatic HSV shedding. 
